Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Among a group of largely HIV-positive gay and bi men, Zepatier (grazoprevir/elbasvir) boasted a 99 percent cure rate.
Harvoni (ledipasvir/sofosbuvir) is proving highly successful at treating hepatitis C among people coinfected with HIV and genotype 1 of hep C...
Advocates argue that the proposed criteria are dangerous for people living with the deadly liver disease.
The Sovaldi/ledipasvir combination pill to treat hepatitis C does not have a clinically significant impact on five common HIV antiretrovirals.
People with hepatitis C virus die 15 years earlier and have a 12-times greater risk of death when compared with those without the virus.
Activist Jules Levin battles for awareness for HIV and hep C
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.